↓ Skip to main content

Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis

Overview of attention for article published in BMC Infectious Diseases, May 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet
twitter
40 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
171 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
Published in
BMC Infectious Diseases, May 2021
DOI 10.1186/s12879-021-06164-x
Pubmed ID
Authors

Toshie Manabe, Dan Kambayashi, Hiroyasu Akatsu, Koichiro Kudo

Twitter Demographics

The data shown below were collected from the profiles of 40 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 171 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 171 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 29 17%
Student > Master 18 11%
Researcher 11 6%
Other 10 6%
Unspecified 10 6%
Other 26 15%
Unknown 67 39%
Readers by discipline Count As %
Medicine and Dentistry 26 15%
Pharmacology, Toxicology and Pharmaceutical Science 25 15%
Biochemistry, Genetics and Molecular Biology 11 6%
Unspecified 9 5%
Chemistry 8 5%
Other 21 12%
Unknown 71 42%

Attention Score in Context

This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2022.
All research outputs
#904,324
of 23,028,364 outputs
Outputs from BMC Infectious Diseases
#208
of 7,725 outputs
Outputs of similar age
#25,196
of 446,618 outputs
Outputs of similar age from BMC Infectious Diseases
#17
of 225 outputs
Altmetric has tracked 23,028,364 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,725 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,618 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 225 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.